Shan Wu
Corporate Officer/Principal bij VIRIDIAN THERAPEUTICS, INC.
Actieve functies van Shan Wu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30-10-2023 | - |
Loopbaan van Shan Wu
Eerdere bekende functies van Shan Wu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 01-10-2021 | 01-09-2023 |
| Corporate Officer/Principal | 01-10-2021 | 01-09-2023 |
Opleiding van Shan Wu
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
